Clinical Trial Update: Cladribine vs Placebo for Non-active Progressive Multiple Sclerosis (CLASP-MS). [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for cladribine vs placebo in non-active progressive multiple sclerosis (CLASP-MS) is currently recruiting in Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Multiple Sclerosis Secondary Progressive

Drugs mentioned

• Cladribine (cladribine)

Snippet

Sponsor: Institute of Psychiatry and Neurology, Warsaw | Conditions: Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis | Phase 2, Phase 3 | Status: RECRUITING